STERIS - STE Stock Forecast, Price & News

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for STERIS in the last year. There are currently 1 hold rating and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" STE shares.
View STE analyst ratings or view top-rated stocks.

5 brokers have issued twelve-month price targets for STERIS's shares. Their STE share price forecasts range from $210.00 to $275.00. On average, they anticipate the company's share price to reach $242.40 in the next twelve months. This suggests a possible upside of 10.7% from the stock's current price.
View analysts price targets for STE or view top-rated stocks among Wall Street analysts.

STERIS's stock was trading at $184.69 at the beginning of the year. Since then, STE stock has increased by 18.6% and is now trading at $219.03.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 8th 2023.
View our STE earnings forecast.

STERIS will be holding an earnings conference call on Thursday, February 9th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-0088 with passcode "8550233".

STERIS plc (NYSE:STE) released its earnings results on Wednesday, November, 9th. The medical equipment provider reported $1.99 EPS for the quarter, missing analysts' consensus estimates of $2.00 by $0.01. The medical equipment provider had revenue of $1.20 billion for the quarter, compared to analysts' expectations of $1.22 billion. STERIS had a positive trailing twelve-month return on equity of 12.75% and a negative net margin of 0.17%. The firm's quarterly revenue was up .3% compared to the same quarter last year. During the same period in the prior year, the business posted $1.99 earnings per share.
Read the conference call transcript.

STERIS announced a quarterly dividend on Wednesday, February 1st. Stockholders of record on Friday, February 24th will be given a dividend of $0.47 per share on Thursday, March 23rd. This represents a $1.88 dividend on an annualized basis and a dividend yield of 0.86%. The ex-dividend date of this dividend is Thursday, February 23rd.
Read our dividend analysis for STE.

STERIS (NYSE:STE) pays an annual dividend of $1.88 per share and currently has a dividend yield of 0.86%.
Read our dividend analysis for STE.

STERIS updated its FY 2023 earnings guidance on Friday, December, 9th. The company provided earnings per share (EPS) guidance of $8.40-$8.60 for the period, compared to the consensus earnings per share estimate of $8.49. The company issued revenue guidance of $4.95 billion-$4.95 billion, compared to the consensus revenue estimate of $4.98 billion.

196 employees have rated STERIS Chief Executive Officer Walter M. Rosebrough, Jr. on Glassdoor.com. Walter M. Rosebrough, Jr. has an approval rating of 79% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other STERIS investors own include Johnson & Johnson (JNJ), Home Depot (HD), AT&T (T), Visa (V), AbbVie (ABBV), Abbott Laboratories (ABT), Pfizer (PFE), Gilead Sciences (GILD), Mastercard (MA) and Medtronic (MDT).

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

STERIS's stock is owned by a number of institutional and retail investors. Top institutional investors include Sustainable Growth Advisers LP (0.82%), Congress Asset Management Co. MA (0.59%), Sumitomo Mitsui Trust Holdings Inc. (0.39%), Villere ST Denis J & Co. LLC (0.33%), Boston Trust Walden Corp (0.24%) and Boston Financial Mangement LLC (0.22%). Insiders that own company stock include Cary L Majors, Cary L Majors, Cynthia L Feldmann, Daniel A Carestio, David B Lewis, Jacqueline B Kosecoff, John Adam Zangerle, Julia Madsen, Karen L Burton, Michael J Tokich, Mohsen Sohi, Renato Tamaro, Richard C Breeden and Walter M Rosebrough Jr.
View institutional ownership trends.

Shares of STE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of STE stock can currently be purchased for approximately $219.03.

STERIS (NYSE:STE) has a market capitalization of $21.86 billion and generates $4.59 billion in revenue each year. The medical equipment provider earns $243.89 million in net income (profit) each year or ($0.11) on an earnings per share basis.

The company employs 16,422 workers across the globe.

STERIS's mailing address is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. The official website for the company is www.steris.com. The medical equipment provider can be reached via phone at (440) 354-2600, via email at julie_winter@steris.com, or via fax at 440-639-4457.